Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement.
about
Ocular drug delivery.Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.Evaluation of active and passive transport processes in corneas extracted from preserved rabbit eyesEffect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.Evaluation of topical hesperetin matrix film for back-of-the-eye deliveryProdrug approach to improve absorption of prednisoloneImmunohistochemical and functional characterization of peptide, organic cation, neutral and basic amino acid, and monocarboxylate drug transporters in human ocular tissues.Vitreal kinetics of quinidine in rabbits in the presence of topically coadministered P-glycoprotein substrates/modulators.Hypoxia alters ocular drug transporter expression and activity in rat and calf models: implications for drug delivery.Advances in ocular drug delivery.Prodrug strategies in ocular drug delivery.Nanotechnology approaches for ocular drug delivery.A comprehensive insight on ocular pharmacokinetics.Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery.Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin.Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
P2860
Q30475605-49F90EF0-644F-4356-94F7-87F6E1FFFCD4Q33558455-F45BB05B-4CA1-4246-8C07-3ABD96FAD5A5Q34141933-CB8FE2A6-CB73-4314-83D8-1092EB6648D6Q34325015-0AFA7808-CB66-4907-93D0-DAE4F03B1DCBQ35602734-BE294E1D-5AC7-42C9-A1A6-EE046B63D03FQ35950189-4962D51F-9DBD-4DB0-8FC4-857FB57075ABQ36573373-B8B80A23-0A73-410D-905E-B6C4574C685DQ37266286-3331758C-C19B-4351-82F9-2B012E8F8274Q37680569-7C5F8103-F184-427B-8521-FFB090904F60Q38003192-FD5890E5-4DA5-49F4-B8A9-108CD1389D8CQ38005228-83A23863-194A-4EB0-BC8A-BB05D5022951Q38098509-EE493D3C-432F-4203-B7DC-582D33D04C9FQ38995367-F42BA50C-BE51-464F-BCAD-08E06D5E23BEQ47444145-858706C1-6A84-4FD2-AF15-ED8F5D3D2018Q50036998-F83F4020-5067-4099-A14E-4054D089F29DQ50278439-7C6011B0-CDC7-4C79-92E0-F2F0EE87A164
P2860
Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transcorneal permeation of L- ...... ersus transporter involvement.
@en
Transcorneal permeation of L- ...... ersus transporter involvement.
@nl
type
label
Transcorneal permeation of L- ...... ersus transporter involvement.
@en
Transcorneal permeation of L- ...... ersus transporter involvement.
@nl
prefLabel
Transcorneal permeation of L- ...... ersus transporter involvement.
@en
Transcorneal permeation of L- ...... ersus transporter involvement.
@nl
P2093
P2860
P1476
Transcorneal permeation of L- ...... ersus transporter involvement.
@en
P2093
Michael A Repka
Rama Sarma Gadepalli
Ramesh Srirangam
Soumyajit Majumdar
Tushar Hingorani
P2860
P304
P356
10.1007/S11095-008-9730-0
P577
2008-10-07T00:00:00Z